Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Agronomics investee Meatable acquires Uncommon Bio platform

(Sharecast News) - Agronomics said on Friday that its portfolio company Meatable has acquired Uncommon Bio's cultured meat technology platform, strengthening its position in the rapidly developing cellular agriculture sector and expanding its capabilities for commercial-scale production. The AIM-traded firm said the deal included Uncommon's key technology, intellectual property, high-performing cell lines and specialist staff, enabling Meatable to integrate its own patented 'opti-ox' system with Uncommon's non-GMO mRNA reprogramming and saRNA differentiation technologies.

Meatable said the combined platform would accelerate time to market, support regulatory approvals across multiple jurisdictions and broaden product development across species including pork, beef, lamb and poultry.

"With this acquisition, Meatable is reinforcing its position as a global leader in cultivated meat, proving what is possible when the world's sharpest minds address one of our greatest challenges - feeding a growing planet amid rising meat demand and shrinking supply," said Jim Mellon, executive chair of Agronomics.

"By combining Uncommon's platform with its own, Meatable will have an enviable offering for prospective customers, offering greater choice and scalability, and answering the global call for a protein supply chain which can help moderate price volatility, and boost food security."

Uncommon chief executive Benjamina Bollag said the company had chosen to focus on therapeutics and wanted "the best home for our technology."

"It's exciting to see Meatable carry our work forward and apply it at scale," he added.

Meatable chief executive Jeff Tripician said the deal "sets a new standard for cultivated meat production," equipping the company to "reliably deliver high-quality cultivated meat at a global scale."

Agronomics had invested £7.9m in Meatable to date, a position carried at £11.7m as at 30 June, representing about 8.1% of the firm's last reported net asset value.

At 1505 BST, shares in Agronomics were down 0.64% at 7.45p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Chesnara's £260m purchase of HSBC Life UK clears regulatory hurdle
(Sharecast News) - Life and pension consolidator Chesnara has received regulatory approval for its £260m acquisition of HSBC's UK life insurance manufacturing business.
GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Orosur nears completion of Pepas drilling
(Sharecast News) - Orosur Mining said drilling at its Pepas gold prospect in Colombia was nearing completion as the company moves toward an initial NI43-101 compliant mineral resource estimate, while first drill holes at its El Pantano project in Argentina have confirmed the presence of a previously undrilled mineral system.
Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.